• Qvella, a Toronto - based molecular
diagnostics company aiming to reduce the time to results in the diagnosis of infections, raised $ 20 million in series B funding.
Not exact matches
Theranos is a
diagnostics company with fast finger - prick blood testing technology that
aims to upend the traditional health care establishments by making it easier, less expensive and less uncomfortable to get tested for various conditions.
It announced a collaboration with a molecular
diagnostics company this week that
aims to ensure that AstraZeneca is «giving the right treatment, to the right patient, the first time.»
The
company says it plans to release a new
diagnostic tool with a future update,
aiming to help gather information about battery issues and allow the
company to better manage performance levels and potential mishaps.